The role of prevention research in HIV vaccine trials. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The role of prevention research in HIV vaccine trials.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S303-5. Unique Identifier : AIDSLINE MED/95169507
Vermund SH; UAB School of Public Health, 35294-0008.

Abstract: The National Institute of Allergy and Infectious Diseases has prepared for HIV vaccine efficacy trials with the hope of having a product which is deemed worthy of testing. This has entailed development of new field research infrastructure and training, in collaboration with many partners. Notably, experts in observational research and experts in field HIV prevention research have joined together in efforts to share their mutually reinforcing experiences. In crafting these potential trial sites, it has become evident that the same criteria that apply in vaccine site suitability should also apply to other prevention clinical trials. These criteria include novel approaches to barriers to sexual transmission, including topical microbicides/spermicides, treatment of sexually transmitted infections, reduction in intrapartum blood contamination, and various strategies to ensure clean needle use. Like vaccines, most of these interventions are theoretically plausible, but remain untested. With or without large scale vaccine trials, these other prevention technologies remain high priorities for HIV research.
Keywords: AIDS Vaccines/ISOLATION & PURIF/*PHARMACOLOGY Clinical Trials/*METHODS Disease Transmission, Vertical Female Human HIV Infections/*PREVENTION & CONTROL/TRANSMISSION Infant, Newborn Male National Institutes of Health (U.S.) Pregnancy Pregnancy Complications, Infectious Research Sex Behavior Substance Abuse, Intravenous United States JOURNAL ARTICLEKWDaidsvaccines/isolation&purif/KWDpharmacologyclinicaltrials/KWDmethodsdiseasetransmission,verticalfemalehumanhivinfections/KWDprevention&control/transmissioninfant,newbornmalenationalinstitutesofhealth(uKWDsKWD)pregnancypregnancycomplications,infectiousresearchsexbehaviorsubstanceabuse,intravenousunitedstatesjournalarticle
950630
M9561109

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .